Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours
Teresa Gelardi(University of Naples Federico II), Claudia De Lorenzo(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli)
Cited by 39
Related Papers
Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs
|British Journal of Cancer|2008|27
A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy
|Oncotarget|2016|25
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2
|Scientific Reports|2021|21
Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy
|International Journal of Molecular Sciences|2022|10